Progressive Development of Pulmonary Invasive Mucinous Adenocarcinoma With SMARCA4‐Deficient
SMARCA4-deficient non-small cell lung cancer is characterized by highly aggressive clinical behavior, diverse tumor subtypes, and complex histological features. The application of the SMARCA4 immunohistochemical marker facilitates accurate identification. This study presents a rare case of SMARCA4-deficient pulmonary invasive mucinous adenocarcinoma with high-grade transformation.
Authors
- Xiaomin Dai (ORCID: https://orcid.org/0000-0001-8833-8521)
- Heng Zheng (ORCID: https://orcid.org/0000-0002-6537-5095)
- Yingying Cui
- Fengli Fu
- Fang Peng
Institutions
- Ningbo No. 2 Hospital (CN)
- Zhejiang Hospital (CN)
- Hangzhou Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Pathology International
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/pin.70095
- Primary Topic
- Chromatin Remodeling and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00